Definium Therapeutics, Inc. (DFTX) stock
DFTXNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$32.08−0.92 (-2.79%)
Close on Nov 13, 2026Market cap $4.31BP/E –Yield –
Definium Therapeutics total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Definium Therapeutics's total debt was $36.66M at Sep 30, 2026. For fiscal 2025 it was $40.58M, up 85.7% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $40.58M | +85.7% |
| FY2024 | Dec 31, 2024 | $21.85M | +54.7% |
| FY2023 | Dec 31, 2023 | $14.13M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $36.66M | -9.2% |
| Q2 FY2026 | Jun 30, 2026 | $36.47M | -11.5% |
| Q1 FY2026 | Mar 31, 2026 | $40.77M | +85.0% |
| Q4 FY2025 | Dec 31, 2025 | $40.58M | +85.7% |
| Q3 FY2025 | Sep 30, 2025 | $40.39M | +66.1% |
| Q2 FY2025 | Jun 30, 2025 | $41.19M | +69.9% |
| Q1 FY2025 | Mar 31, 2025 | $22.04M | +55.3% |
| Q4 FY2024 | Dec 31, 2024 | $21.85M | +54.7% |
| Q3 FY2024 | Sep 30, 2024 | $24.31M | +72.8% |
| Q2 FY2024 | Jun 30, 2024 | $24.25M | – |
| Q1 FY2024 | Mar 31, 2024 | $14.19M | – |
| Q4 FY2023 | Dec 31, 2023 | $14.13M | – |
| Q3 FY2023 | Sep 30, 2023 | $14.07M | – |
See a number that looks wrong?